Okyo Pharma Limited (OKYO)

Feb 26, 2026

OKYO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Feb 26, 2026

Feb 23, 2026

OKYO Pharma to present first-in-human urcosimod data at ARVO 2026 - Proactive financial news

Feb 23, 2026

Feb 23, 2026

OKYO Pharma’s Urcosimod NCP Data Selected for Presentation at ARVO 2026 - TipRanks

Feb 23, 2026

Feb 23, 2026

OKYO Pharma's Urcosimod Selected for Presentation at ARVO 2026 Annual Meeting Following Positive Phase 2a Trial Results for Neuropathic Corneal Pain Treatment - Quiver Quantitative

Feb 23, 2026

Feb 23, 2026

OKYO (Nasdaq: OKYO) to present Fast Track NCP therapy data at ARVO 2026 - Stock Titan

Feb 23, 2026

Feb 23, 2026

OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress - GlobeNewswire

Feb 23, 2026

Feb 23, 2026

Experimental eye drop eases nerve-related eye pain in first human study - Stock Titan

Feb 23, 2026

Feb 23, 2026

Analysts Set OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Target Price at $6.00 - Defense World

Feb 23, 2026

Feb 22, 2026

Piper Sandler Initiates Coverage on OKYO Pharma (NASDAQ:OKYO) - Defense World

Feb 22, 2026

Feb 21, 2026

OKYO Pharma (NASDAQ:OKYO) Raised to "Strong-Buy" at Piper Sandler - MarketBeat

Feb 21, 2026

Feb 21, 2026

Piper Sandler initiates OKYO Pharma stock with Overweight rating By Investing.com - Investing.com Nigeria

Feb 21, 2026

Feb 20, 2026

How OKYO Pharma Limited stock compares to industry benchmarksWeekly Trade Review & Daily Volume Surge Signals - mfd.ru

Feb 20, 2026

Feb 20, 2026

CEO Moves: Is OKYO Pharma Limited a turnaround story2025 Pullback Review & Weekly High Return Stock Forecasts - baoquankhu1.vn

Feb 20, 2026

Feb 20, 2026

How interest rate cuts could boost OKYO Pharma Limited stockJuly 2025 Market Mood & Reliable Breakout Stock Forecasts - mfd.ru

Feb 20, 2026

Feb 20, 2026

Piper Sandler initiates OKYO Pharma stock with Overweight rating - Investing.com South Africa

Feb 20, 2026

Feb 20, 2026

OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Feb 20, 2026

Feb 20, 2026

Piper Sandler Initiates Coverage on OKYO Pharma With Overweight Rating, $7 Price Target - marketscreener.com

Feb 20, 2026

Feb 19, 2026

Big Money Moves: How interest rate cuts could boost OKYO Pharma Limited stock2025 Investor Takeaways & Entry and Exit Point Strategies - mfd.ru

Feb 19, 2026

Feb 18, 2026

OKYO Pharma prices public offering at $1.85/share to raise up to $20M - MSN

Feb 18, 2026

Feb 18, 2026

OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares - VisionMonday.com

Feb 18, 2026

Feb 17, 2026

Small cap wrap: Trust Stamp, HIVE Digital Technologies, OKYO Pharma... - Proactive financial news

Feb 17, 2026

Feb 17, 2026

OKYO Pharma has analysts bullish as FDA endorses Phase 2b/3 trial in neuropathic corneal pain - Proactive financial news

Feb 17, 2026

Feb 16, 2026

What risks investors should watch in OKYO Pharma Limited stock2025 Market Sentiment & Technical Entry and Exit Alerts - mfd.ru

Feb 16, 2026

Feb 16, 2026

Options Flow: Is OKYO Pharma Limited exposed to political riskQuarterly Investment Review & Safe Capital Allocation Plans - baoquankhu1.vn

Feb 16, 2026

Feb 15, 2026

Income Plays: Is Amylyx Pharmaceuticals Inc in accumulation or distribution phaseJuly 2025 Patterns & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Feb 15, 2026

Feb 15, 2026

Support Test: Is APWC a strong candidate for buy and holdJuly 2025 Review & Expert Curated Trade Setups - baoquankhu1.vn

Feb 15, 2026

Feb 14, 2026

Can OKYO Pharma Limited stock deliver sustainable ROEPortfolio Performance Report & Growth Focused Stock Reports - mfd.ru

Feb 14, 2026

Feb 14, 2026

OKYO Pharma Prices Public Offering at $1.85 per Share - Intellectia AI

Feb 14, 2026

Feb 14, 2026

OKYO PE Ratio & Valuation, Is OKYO Overvalued - Intellectia AI

Feb 14, 2026

Feb 14, 2026

Is OKYO Pharma Limited a turnaround storyWeekly Stock Analysis & Reliable Price Breakout Signals - mfd.ru

Feb 14, 2026

Feb 14, 2026

Small cap wrap: OKYO Pharma, HIVE Digital Technologies, Synchronoss Technologies... - Proactive financial news

Feb 14, 2026

Feb 13, 2026

Published on: 2026-02-14 12:01:38 - baoquankhu1.vn

Feb 13, 2026

Feb 13, 2026

OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Sees Significant Increase in Short Interest - MarketBeat

Feb 13, 2026

Feb 13, 2026

OKYO Pharma launches underwritten public offering of ordinary shares - MSN

Feb 13, 2026

Feb 13, 2026

OKYO Pharma announces $20 million public offering of ordinary shares - Investing.com South Africa

Feb 13, 2026

Feb 13, 2026

OKYO Pharma announces $20 million public offering of ordinary shares By Investing.com - Investing.com Canada

Feb 13, 2026

Feb 13, 2026

OKYO Pharma Prices $20 Million Underwritten Share Offering to Fund Clinical Development - TipRanks

Feb 13, 2026

Feb 13, 2026

OKYO Pharma stock tumbles on $20 million public offering announcement - Investing.com South Africa

Feb 13, 2026

Feb 13, 2026

OKYO Pharma stock tumbles on $20 million public offering announcement By Investing.com - Investing.com Canada

Feb 13, 2026

Feb 13, 2026

OKYO Pharma prices $20M offering to fund late-stage eye drug trial - Yahoo Finance

Feb 13, 2026

Feb 13, 2026

OKYO Pharma Prices $20 Million Public Share Offering to Fund Eye Disease Pipeline - TipRanks

Feb 13, 2026

Feb 13, 2026

What’s the analyst consensus on OKYO Pharma LimitedOptions Play & Technical Entry and Exit Tips - mfd.ru

Feb 13, 2026